Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Judiciary Committee debate exposes split over requiring disclosure of third‑party litigation funders
Loading...
Summary
Members engaged in a long cross‑party debate on H.R.7015. Proponents argued transparency is needed to prevent foreign or strategic influence and to protect clients; opponents warned disclosures would chill funding that enables access to courts for ordinary plaintiffs and could advantage large corporate defendants.
The Judiciary Committee opened debate on H.R.7015, legislation that would require parties to disclose third‑party litigation funders and certain funding arrangements to the court in civil actions.
Representative Issa, the bill’s sponsor, said disclosure is a transparency safeguard: "Disclosure will ensure that the courts know who's involved," he said, arguing funding can shift control of litigation strategy and potentially introduce foreign influence into U.S. courts. Supporters cited national‑security concerns about foreign adversaries using litigation funding as a tool.
Opponents across the aisle and some conservative groups countered that the bill would chill financing that allows ordinary plaintiffs and small inventors to bring meritorious claims against large corporations. Representative Jayapal said third‑party funding "levels the playing field for ordinary Americans who face powerful corporations," and warned forced disclosure to defendants could enable harassment and strategic delay.
Representative Massey offered an amendment to narrow the bill’s scope to disclosures only where the funder is a foreign person or entity or an entity organized and principally operating under foreign law; the amendment drew cross‑party support in discussion and was under consideration when the committee recessed for floor votes.
The session included extended colloquies about how to balance national‑security concerns with access to court, whether in‑camera review by a judge is sufficient, and how to narrow definitions so the policy targets foreign adversaries rather than domestic funders that enable plaintiffs to proceed.
